About Parabilis Medicines Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://parabilismed.com
Frequently Asked Questions
What is the 52-week range for PBLS?
The 52-week high is $42.485 and the 52-week low is $24.51.
What is the P/E ratio for PBLS?
The P/E ratio data is currently unavailable.
What is the dividend yield for PBLS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
ROE data is currently unavailable.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for PBLS over the last few months:
Latest PBLS News
Sixty Degree Capital Extends Its Track Record as Five Portfolio Companies Enter the Public Markets in 2026
Sixty Degree Capital ("SDC"), a global, multi-stage venture capital firm investing across technology and healthcare, continued its strong portfolio momentum in 2026. Building on the firm's history of successful exits, five SDC portfolio companies have completed initial public offerings in 2026, including two record-setting offerings.
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
LONDON and NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced the appointment of Alan M. Sebulsky to its Board of Directors. Mr. Sebulsky is a veteran healthcare portfolio manager and biopharmaceutical investment analyst with more than 40 years of experience in public company investment, financial strategy, portfolio evaluation and growth, and board leadership. Mr. Sebulsky most rec
Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday
U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal. Securitize and biotech shares rallied.
Parabilis Medicines, Inc. (PBLS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Parabilis Medicines, Inc. (PBLS) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 2:35 PM EDTCompany ParticipantsMathai Mammen -...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-22 | Tendler Craig | +20,294 | - | - |
| 2026-07-22 | RA CAPITAL MANAGEMENT, L.P. | +47,250 | $29.77 | $1,406,633 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. | +37,723 | $30 | $1,131,690 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. | +6,504 | $29.17 | $189,722 |
| 2026-07-21 | RA CAPITAL MANAGEMENT, L.P. | +21,696 | $27.96 | $606,620 |
| 2026-07-20 | RA CAPITAL MANAGEMENT, L.P. | +32,987 | $27.72 | $914,400 |
| 2026-07-20 | RA CAPITAL MANAGEMENT, L.P. | +98,433 | $27.13 | $2,670,487 |